Crossref journal-article
Elsevier BV
NeuroToxicology (78)
Bibliography

Anantharam, V., Kaul, S., Song, C., Kanthasamy, A., & Kanthasamy, A. G. (2007). Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells. NeuroToxicology, 28(5), 988–997.

Authors 5
  1. Vellareddy Anantharam (first)
  2. Siddharth Kaul (additional)
  3. Chunjuan Song (additional)
  4. Arthi Kanthasamy (additional)
  5. Anumantha G. Kanthasamy (additional)
References 76 Referenced 99
  1. 10.1523/JNEUROSCI.22-05-01738.2002 / J Neurosci / Caspase-3-dependent proteolytic cleavage of protein kinase Cdelta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl by Anantharam (2002)
  2. 10.1196/annals.1332.017 / Ann NY Acad Sci / Blockade of PKCdelta proteolytic activation by loss of function mutants rescues mesencephalic dopaminergic neurons from methylcyclopentadienyl manganese tricarbonyl (MMT)-induced apoptotic cell death by Anantharam (2004)
  3. 10.3233/JAD-2004-6S602 / J Alzheimers Dis / Iron dysregulation and Parkinson's disease by Andersen (2004)
  4. 10.1111/j.1749-6632.2003.tb07470.x / Ann NY Acad Sci / Mitochondria, oxidative damage, and inflammation in Parkinson's disease by Beal (2003)
  5. 10.1602/neurorx.2.3.484 / NeuroRx / Toxin-induced models of Parkinson's disease by Bove (2005)
  6. 10.1016/S0925-4439(98)00083-0 / Biochim Biophys Acta / The Parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism by Cassarino (1999)
  7. 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO;2-E / J Neurosci Res / Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK by Choi (1999)
  8. 10.1016/S0896-6273(03)00568-3 / Neuron / Parkinson's disease: mechanisms and models by Dauer (2003)
  9. 10.1126/science.1087753 / Science / Molecular pathways of neurodegeneration in Parkinson's disease by Dawson (2003)
  10. 10.1016/S1474-4422(03)00501-5 / Lancet Neurol / The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? by Di Monte (2003)
  11. 10.1016/S0891-5849(98)00050-1 / Free Radic Biol Med / Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species by Drukarch (1998)
  12. 10.1042/BJ20050287 / Biochem J / PKCdelta mediates up-regulation of NOX1, a catalytic subunit of NADPH oxidase, via transactivation of the EGF receptor: possible involvement of PKCdelta in vascular hypertrophy by Fan (2005)
  13. 10.1111/j.1749-6632.2003.tb07469.x / Ann NY Acad Sci / Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease by Fiskum (2003)
  14. 10.1093/hmg/ddi308 / Hum Mol Genet / Molecular pathogenesis of Parkinson's disease by Gandhi (2005)
  15. 10.1523/JNEUROSCI.23-15-06181.2003 / J Neurosci / Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons by Gao (2003)
  16. 10.1096/fj.03-0109fje / FASEB J / Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease by Gao (2003)
  17. 10.1016/j.cardiores.2006.05.004 / Cardiovasc Res / NADPH oxidases: new kids on the block by Geiszt (2006)
  18. 10.1126/science.1098966 / Science / Biomedicine. Parkinson's—divergent causes, convergent mechanisms by Greenamyre (2004)
  19. 10.1016/j.expneurol.2005.01.013 / Exp Neurol / Oxidative stress and inflammation in Parkinson's disease: is there a causal link? by Hald (2005)
  20. 10.1152/ajplung.00015.2005 / Am J Physiol Lung Cell Mol Physiol / Effect of p47phox gene deletion on ROS production and oxygen sensing in mouse carotid body chemoreceptor cells by He (2005)
  21. 10.1111/j.1749-6632.2003.tb07478.x / Ann NY Acad Sci / The role of glial reaction and inflammation in Parkinson's disease by Hirsch (2003)
  22. 10.1007/978-3-7091-0643-3_6 / J Neural Transm Suppl / Animal models of Parkinson's disease in rodents induced by toxins: an update by Hirsch (2003)
  23. 10.1016/j.abb.2006.11.009 / Arch Biochem Biophys / Protein kinase C-alpha and -delta are required for NADPH oxidase activation in WKYMVm-stimulated IMR90 human fibroblasts by Iaccio (2006)
  24. 10.1016/j.freeradbiomed.2006.01.009 / Free Radic Biol Med / NOX1/NADPH oxidase negatively regulates nerve growth factor-induced neurite outgrowth by Ibi (2006)
  25. 10.1089/ars.2006.8.1583 / Antioxid Redox Signal / NADPH oxidases of the brain: distribution, regulation, and function by Infanger (2006)
  26. 10.1172/JCI200317638 / J Clin Invest / Oxidative stress and nitration in neurodegeneration: cause, effect, or association? by Ischiropoulos (2003)
  27. 10.1002/ana.10483 / Ann Neurol / Oxidative stress in Parkinson's disease by Jenner (2003)
  28. 10.1042/bj20021525 / Biochem J / 1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide by Kalivendi (2003)
  29. 10.1089/152308603770310275 / Antioxid Redox Signal / Role of proteolytic activation of protein kinase Cdelta in oxidative stress-induced apoptosis by Kanthasamy (2003)
  30. 10.1016/j.freeradbiomed.2006.08.016 / Free Radic Biol Med / A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKCdelta) protects against dopaminergic neuronal degeneration in Parkinson's disease models by Kanthasamy (2006)
  31. 10.1046/j.1460-9568.2003.02864.x / Eur J Neurosci / Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration by Kaul (2003)
  32. 10.1016/j.molbrainres.2005.05.022 / Brain Res Mol Brain Res / Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death by Kaul (2005)
  33. 10.1074/jbc.M501092200 / J Biol Chem / Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cdelta in dopaminergic neuronal cells by Kaul (2005)
  34. 10.1016/S0891-5849(01)00726-2 / Free Radic Biol Med / Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells by Kitazawa (2001)
  35. 10.1016/S0306-4522(03)00226-4 / Neuroscience / Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration by Kitazawa (2003)
  36. 10.1007/s00415-002-1201-7 / J Neurol / Free radicals in Parkinson's disease by Koutsilieri (2002)
  37. 10.1124/jpet.104.078469 / J Pharmacol Exp Ther / Protein kinase Cdelta is a key downstream mediator of manganese-induced apoptosis in dopaminergic neuronal cells by Latchoumycandane (2005)
  38. 10.1016/S1474-4422(04)00782-3 / Lancet Neurol / Mitochondria back in the spotlight in Parkinson's disease by Love (2004)
  39. 10.1523/JNEUROSCI.20-15-05715.2000 / J Neurosci / Delayed mitochondrial dysfunction in excitotoxic neuron death: cytochrome c release and a secondary increase in superoxide production by Luetjens (2000)
  40. 10.1007/s11064-006-9038-6 / Neurochem Res / Dopamine promotes the survival of embryonic striatal cells: involvement of superoxide and endogenous NADPH oxidase by Ma (2006)
  41. 10.1016/j.molbrainres.2004.09.014 / Brain Res Mol Brain Res / Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease? by Maguire-Zeiss (2005)
  42. 10.2741/2130 / Front Biosci / Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders by Mancuso (2007)
  43. 10.1385/JMN:24:3:401 / J Mol Neurosci / Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (−)-epigallocatechin-3-gallate by Mandel (2004)
  44. 10.1016/j.neuroscience.2006.03.069 / Neuroscience / Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration by McCormack (2006)
  45. 10.1080/10715760500176866 / Free Radic Res / Rac1-NADPH oxidase-regulated generation of reactive oxygen species mediates glutamate-induced apoptosis in SH-SY5Y human neuroblastoma cells by Nikolova (2005)
  46. 10.1016/S0378-4274(02)00076-0 / Toxicol Lett / Role of hydroxyl radical formation in neurotoxicity as revealed by in vivo free radical trapping by Obata (2002)
  47. 10.1016/j.ejphar.2005.01.004 / Eur J Pharmacol / Antioxidants inhibit human endothelial cell functions through down-regulation of endothelial nitric oxide synthase activity by Polytarchou (2005)
  48. 10.1016/j.parkreldis.2004.10.012 / Parkinsonism Relat Disord / Pathogenesis of nigral cell death in Parkinson's disease by Przedborski (2005)
  49. 10.1089/ars.2005.7.685 / Antioxid Redox Signal / Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease by Przedborski (2005)
  50. 10.1023/B:JOBB.0000041771.66775.d5 / J Bioenerg Biomemb / MPTP as a mitochondrial neurotoxic model of Parkinson's disease by Przedborski (2004)
  51. 10.1016/j.nbd.2006.10.008 / Neurobiol Dis / Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration by Purisai (2006)
  52. 10.1016/j.neurobiolaging.2005.09.036 / Neurobiol Aging / A key role for the microglial NADPH oxidase in APP-dependent killing of neurons by Qin (2006)
  53. 10.1002/jnr.21005 / J Neurosci Res / NADPH oxidase inhibitor diphenyliodonium abolishes lipopolysaccharide-induced down-regulation of transferrin receptor expression in N2a and BV-2 cells by Reis (2006)
  54. {'key': '10.1016/j.neuro.2007.08.008_bib54', 'first-page': '373', 'article-title': "Role of cytokines in inflammatory process in Parkinson's disease", 'author': 'Sawada', 'year': '2006', 'journal-title': 'J Neural Transm Suppl'} / J Neural Transm Suppl / Role of cytokines in inflammatory process in Parkinson's disease by Sawada (2006)
  55. {'key': '10.1016/j.neuro.2007.08.008_bib55', 'first-page': '15', 'article-title': "Pathogenesis of Parkinson's disease", 'volume': '6', 'author': 'Schapira', 'year': '1997', 'journal-title': 'Baillieres Clin Neurol'} / Baillieres Clin Neurol / Pathogenesis of Parkinson's disease by Schapira (1997)
  56. 10.1073/pnas.2235648100 / Proc Natl Acad Sci USA / NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells by Schneider (2003)
  57. 10.1007/s00441-004-0954-y / Cell Tissue Res / Neuronal pathology in Parkinson's disease by Schulz (2004)
  58. 10.1016/S0006-8993(03)03364-X / Brain Res / NADPH oxidase immunoreactivity in the mouse brain by Serrano (2003)
  59. {'key': '10.1016/j.neuro.2007.08.008_bib59', 'first-page': '657', 'article-title': "Pathogenesis of Parkinson's disease", 'volume': '2', 'author': 'Sherer', 'year': '2001', 'journal-title': 'Curr Opin Investig Drugs'} / Curr Opin Investig Drugs / Pathogenesis of Parkinson's disease by Sherer (2001)
  60. 10.1196/annals.1332.016 / Ann NY Acad Sci / The role of alpha-synuclein in both neuroprotection and neurodegeneration by Sidhu (2004)
  61. 10.1016/j.molbrainres.2004.09.017 / Brain Res Mol Brain Res / The MPTP model of Parkinson's disease by Smeyne (2005)
  62. 10.1016/j.neuro.2006.06.006 / Neurotoxicology / Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models by Sun (2006)
  63. 10.1111/j.1471-4159.2007.04670.x / J Neurochem / The roles of NADPH oxidase and phospholipases A(2) in oxidative and inflammatory responses in neurodegenerative diseases by Sun (2007)
  64. 10.1089/ars.2006.8.1523 / Antioxid Redox Signal / Regulation of novel superoxide-producing NAD(P)H oxidases by Takeya (2006)
  65. 10.1046/j.1460-9568.2003.02781.x / Eur J Neurosci / Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype by Thiruchelvam (2003)
  66. 10.1093/brain/awf068 / Brain / Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease by Tikka (2002)
  67. {'key': '10.1016/j.neuro.2007.08.008_bib67', 'first-page': 're8', 'article-title': 'Localizing NADPH oxidase-derived ROS', 'volume': '349', 'author': 'Ushio-Fukai', 'year': '2006', 'journal-title': 'Sci STKE'} / Sci STKE / Localizing NADPH oxidase-derived ROS by Ushio-Fukai (2006)
  68. 10.1080/10715760500539121 / Free Radic Res / Involvement of protein kinase Cdelta in the activation of NADPH oxidase and the phagocytosis of neutrophils by Waki (2006)
  69. 10.1016/j.brainres.2006.03.060 / Brain Res / Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus by Wang (2006)
  70. {'key': '10.1016/j.neuro.2007.08.008_bib70', 'first-page': 'RA17', 'article-title': "Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease", 'volume': '11', 'author': 'Watanabe', 'year': '2005', 'journal-title': 'Med Sci Monit'} / Med Sci Monit / Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease by Watanabe (2005)
  71. 10.2174/092986706776055760 / Curr Med Chem / An inflammatory pathomechanism for Parkinson's disease? by Wersinger (2006)
  72. 10.1016/j.mcn.2003.11.011 / Mol Cell Neurosci / Suppression of caspase-3-dependent proteolytic activation of protein kinase C delta by small interfering RNA prevents MPP+-induced dopaminergic degeneration by Yang (2004)
  73. 10.1111/j.1460-9568.2004.03254.x / Eur J Neurosci / Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease by Yasuhara (2004)
  74. 10.1196/annals.1306.025 / Ann NY Acad Sci / Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28 by Youdim (2004)
  75. 10.1189/jlb.0504284 / J Leukoc Biol / Protein kinase Cdelta regulates p67phox phosphorylation in human monocytes by Zhao (2005)
  76. 10.1016/S1353-8020(02)00019-6 / Parkinsonism Relat Disord / Increased dopamine turnover after partial loss of dopaminergic neurons: compensation or toxicity? by Zigmond (2002)
Dates
Type When
Created 18 years ago (Aug. 28, 2007, 7:18 a.m.)
Deposited 1 year, 6 months ago (Feb. 17, 2024, 11:37 a.m.)
Indexed 3 months, 1 week ago (May 16, 2025, 9:04 a.m.)
Issued 17 years, 11 months ago (Sept. 1, 2007)
Published 17 years, 11 months ago (Sept. 1, 2007)
Published Print 17 years, 11 months ago (Sept. 1, 2007)
Funders 1
  1. National Institutes of Health 10.13039/100000002

    Region: Americas

    gov (National government)

    Labels3
    1. Institutos Nacionales de la Salud
    2. US National Institutes of Health
    3. NIH
    Awards3
    1. ES10586
    2. NS38644
    3. NS45133

@article{Anantharam_2007, title={Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells}, volume={28}, ISSN={0161-813X}, url={http://dx.doi.org/10.1016/j.neuro.2007.08.008}, DOI={10.1016/j.neuro.2007.08.008}, number={5}, journal={NeuroToxicology}, publisher={Elsevier BV}, author={Anantharam, Vellareddy and Kaul, Siddharth and Song, Chunjuan and Kanthasamy, Arthi and Kanthasamy, Anumantha G.}, year={2007}, month=sep, pages={988–997} }